Ottobock to Distribute MyoPro® to Orthotics and Prosthetics Practices Throughout Country
tobock_300x300-1.jpg” alt=”” width=”300″ height=”300″ />CAMBRIDGE, Mass., November 03, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that its Application for a Canadian Medical Device License has been approved by Health Canada. With the license, Myomo and its distribution partner, Ottobock, are now entering the Canadian market for commercial sale of the MyoPro myolelectric arm orthosis (powered brace). Read more.